CVS Says New Cholesterol Drug Types Could Be Costly

By: via Benzinga
A new type of cholesterol drug in development by Amgen, Inc. (NASDAQ: AMGN) and another by Sanofi SA (ADR) (NYSE: SNY) with Regeneron ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.